CAS:14371-10-9|trans-Cinnamaldehyde

CAS:14371-10-9|trans-Cinnamaldehyde

Catalogue Number:C442020
Chemical Name:trans-Cinnamaldehyde
Synonyms:(2E)-3-Phenyl-2-propenal; (E)-3-Phenyl-2-propenal; (E)-Cinnamaldehyde; (E)-3-Phenylacrolein; (E)-3-Phenylprop-2-en-1-al; (E)-3-Phenylprop-2-enal; (E)-3-Phenylprop-2-enone; (E)-3-Phenylpropenal; (E)-Cinnamaldehyde; E-Cinnamyl aldehyde; trans-3-Phenyl-2-propenal; trans-3-Phenylpropenal; trans-Benzenepropenal; trans-Cinnamic Aldehyde; trans-Cinnamylaldehyde
CAS Number:14371-10-9
Molecular Formula:C₉H₈O
Appearance:Clear Yellow Oil
Molecular Weight:132.16
Storage:4°C
Solubility:Chloroform (Slightly), DMSO (Soluble), Methanol (Sparingly)
Stability
Hygroscopic
Category:Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Boiling Point
250-253В°C at 760 Torr (Scifinder)
Applications:trans-Cinnamaldehyde is an aromatic aldehyde that is derived from Cinnamomi cortex, the dried bark of the Cinnamomum cassia tree. trans-Cinnamaldehyde is a known cause of allergic contact dermatitis (ACD) in humans and is a major component of cinnamon oil. trans-Cinnamaldehyde also exhibits cytotoxic effects on human leukemia cells.
References:Hayashi, K., et al.: Antivir. Res., 74, 1 (2007); He, Z., et al.: J. Agr. Food Chem., 53, 2424 (2005); Peters, M. & Caldwell, J.: Food Chem. Toxicol., 32, 869 (1994); Smith, C., et al.: Toxicol. Appl. Pharm., 168, 189 (2000); Zhang, J., et al.: Acta. Pharm. Sinic., 31, 861 (2010)
To ensure the stability of our products, the efficient express delivery service will be used. We also guarantee that the products will be shipped in the box with layers of tapes to protect them against damage. The extremely low temperature products will be wrapped with dried ice, and the low temperature products will be delivered with ice bags. As for the products stored at room temperature, they will not be packed with ice bags or dried ice. Taskcm is committed to providing cost-effective products that facilitate drug delivery with our customers.
Email:sales@ebclink.com

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *